SynBiotic SE Welcomes U.S. Cannabis Reclassification as Catalyst for Global Market Growth
I'm PortAI, I can summarize articles.
SynBiotic SE has welcomed the U.S. cannabis reclassification from Schedule I to Schedule III, viewing it as a catalyst for global market growth. The company believes this shift will open new medical channels in the U.S. and increase pressure on Europe, especially Germany, to harmonize cannabis regulations. SynBiotic is committed to aligning its strategy with regulatory clarity and sustainable growth to capitalize on the evolving international cannabis market.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments